1. Home
  2. SSKN vs NKGN Comparison

SSKN vs NKGN Comparison

Compare SSKN & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSKN
  • NKGN
  • Stock Information
  • Founded
  • SSKN 1989
  • NKGN 2017
  • Country
  • SSKN United States
  • NKGN United States
  • Employees
  • SSKN N/A
  • NKGN 63
  • Industry
  • SSKN Medical/Dental Instruments
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SSKN Health Care
  • NKGN Health Care
  • Exchange
  • SSKN Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • SSKN 14.5M
  • NKGN 14.1M
  • IPO Year
  • SSKN 2005
  • NKGN N/A
  • Fundamental
  • Price
  • SSKN $2.63
  • NKGN $0.41
  • Analyst Decision
  • SSKN
  • NKGN
  • Analyst Count
  • SSKN 0
  • NKGN 0
  • Target Price
  • SSKN N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • SSKN 12.2K
  • NKGN 447.9K
  • Earning Date
  • SSKN 11-12-2024
  • NKGN 11-12-2024
  • Dividend Yield
  • SSKN N/A
  • NKGN N/A
  • EPS Growth
  • SSKN N/A
  • NKGN N/A
  • EPS
  • SSKN N/A
  • NKGN N/A
  • Revenue
  • SSKN $32,729,999.00
  • NKGN N/A
  • Revenue This Year
  • SSKN N/A
  • NKGN N/A
  • Revenue Next Year
  • SSKN $8.71
  • NKGN N/A
  • P/E Ratio
  • SSKN N/A
  • NKGN N/A
  • Revenue Growth
  • SSKN N/A
  • NKGN N/A
  • 52 Week Low
  • SSKN $2.51
  • NKGN $0.36
  • 52 Week High
  • SSKN $7.10
  • NKGN $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SSKN 36.64
  • NKGN 32.54
  • Support Level
  • SSKN $2.57
  • NKGN $0.36
  • Resistance Level
  • SSKN $2.86
  • NKGN $0.40
  • Average True Range (ATR)
  • SSKN 0.21
  • NKGN 0.06
  • MACD
  • SSKN -0.05
  • NKGN 0.01
  • Stochastic Oscillator
  • SSKN 9.52
  • NKGN 13.79

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: